603229 奧翔藥業
按盤價 
11.990 +0.180 (+1.524%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.107 | 14.095 | 17.333 | 12.254 | 9.800 |
| 總資產報酬率 ROA (%) | 3.751 | 9.641 | 11.330 | 9.061 | 7.658 |
| 投入資產回報率 ROIC (%) | 4.266 | 11.433 | 13.573 | 10.326 | 6.951 | 邊際利潤分析 |
| 銷售毛利率 (%) | 58.286 | 55.048 | 51.501 | 54.787 | 56.434 |
| 營業利潤率 (%) | 43.320 | 35.607 | 33.708 | 28.112 | 23.608 |
| 息稅前利潤/營業總收入 (%) | 41.260 | 31.479 | 27.939 | 28.989 | 27.163 |
| 淨利潤/營業總收入 (%) | 37.380 | 31.086 | 30.786 | 25.615 | 21.218 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 102.874 | 96.382 | 98.049 | 95.144 | 100.579 |
| 價值變動淨收益/利潤總額(%) | 0.000 | 0.241 | 2.473 | 7.317 | -4.871 |
| 營業外收支淨額/利潤總額(%) | -0.267 | -0.021 | -0.725 | -0.477 | -1.168 | 償債能力分析 |
| 流動比率 (X) | 2.375 | 2.172 | 1.525 | 1.924 | 4.018 |
| 速動比率 (X) | 1.956 | 1.699 | 1.095 | 1.465 | 3.238 |
| 資產負債率 (%) | 25.656 | 27.443 | 36.893 | 31.783 | 18.442 |
| 帶息債務/全部投入資本 (%) | 14.997 | 14.951 | 20.263 | 20.519 | -- |
| 股東權益/帶息債務 (%) | 557.182 | 558.661 | 384.038 | 384.451 | 1,150.875 |
| 股東權益/負債合計 (%) | 289.774 | 264.394 | 171.056 | 214.630 | 442.250 |
| 利息保障倍數 (X) | -21.211 | -7.639 | -5.056 | 28.669 | 7.095 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 63.452 | 58.966 | 47.334 | 35.325 | 0.000 |
| 存貨周轉天數 (天) | 242.483 | 336.194 | 273.793 | 303.018 | 0.000 |
| 備註： | 即時報價更新時間為 07/05/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
